Related references
Note: Only part of the references are listed.The role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter
Paradesi Naidu Gollavilli et al.
ONCOGENE (2021)
Combined analysis of miR-200 family and its significance for breast cancer
Andrea Fontana et al.
SCIENTIFIC REPORTS (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy
Ziqi Yu et al.
CANCERS (2021)
MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells
Y. Zuo et al.
NEOPLASMA (2020)
Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
Chara Papadaki et al.
Oncotarget (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
Isaac Garcia-Murillas et al.
JAMA ONCOLOGY (2019)
MiR-200 family and cancer: From a meta-analysis view
Guo-Liang Huang et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
SEOM clinical guidelines in early stage breast cancer (2018)
F. Ayala de la Pena et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
Yu Gao et al.
SCIENTIFIC REPORTS (2019)
Downregulation of LINC00894-002 Contributes to Tamoxifen Resistance by Enhancing the TGF-β Signaling Pathway
Xiulei Zhang et al.
BIOCHEMISTRY-MOSCOW (2018)
MicroRNAs in regulation of triple-negative breast cancer progression
Dominika Piasecka et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Differential microRNA expression in breast cancer with different onset age
Hsiu-Pei Tsai et al.
PLOS ONE (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
Babak Nami et al.
CANCERS (2018)
miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/beta-Catenin Axis
Bingjie Liu et al.
THERANOSTICS (2018)
Epigenetic Silencing of miR-200c in Breast Cancer Is Associated With Aggressiveness and Is Modulated by ZEB1
Valentina Damiano et al.
GENES CHROMOSOMES & CANCER (2017)
The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells
Farheen Alam et al.
TUMOR BIOLOGY (2017)
microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival
Tiefeng Jin et al.
ONCOTARGET (2017)
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells
Lourdes Sanchez-Cid et al.
ONCOTARGET (2017)
The good-cop bad-cop TGF-beta role in breast cancer modulated by non-coding RNAs
Diana Gulei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
MicroRNA-200c and microRNA-141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer
Guangxin Zhang et al.
BREAST CANCER RESEARCH (2017)
Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis
Feng Xu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes
R. Perdigao-Henriques et al.
ONCOGENE (2016)
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis
Dharanija Madhavan et al.
CARCINOGENESIS (2016)
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
Subtype-specific micro-RNA expression signatures in breast cancer progression
Vilde D. Haakensen et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Distribution of miRNA expression across human tissues
Nicole Ludwig et al.
NUCLEIC ACIDS RESEARCH (2016)
The Uncontrolled Sialylation is Related to Chemoresistant Metastatic Breast Cancer
Luca Roncati et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
The Role of MicroRNAs in the Chemoresistance of Breast Cancer
Jing Wang et al.
DRUG DEVELOPMENT RESEARCH (2015)
Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
J. Knezevic et al.
ONCOGENE (2015)
Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance
Eun Young Park et al.
CANCER RESEARCH (2014)
miR-200-containing extracellular vesicles promote breast cancer cell metastasis
Minh T. N. Le et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status
Sigrid Hatse et al.
PLOS ONE (2014)
Intercellular Transport of MicroRNAs
Reinier A. Boon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling
Yong Chen et al.
MOLECULAR MEDICINE REPORTS (2013)
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII-Tubulin Expression as a Predictive Marker
Cristina Saura et al.
ONCOLOGIST (2013)
Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation
J. S. Hall et al.
BRITISH JOURNAL OF CANCER (2012)
Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
Dharanija Madhavan et al.
CLINICAL CANCER RESEARCH (2012)
Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles
Limin Li et al.
PLOS ONE (2012)
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
Manav Korpal et al.
NATURE MEDICINE (2011)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer
S. Uhlmann et al.
ONCOGENE (2010)
Breast cancer chemoresistance: Emerging importance of cancer stem cells
Suebwong Chuthapisith et al.
SURGICAL ONCOLOGY-OXFORD (2010)
Taxanes, microtubules and chemoresistant breast cancer
Barbara T. McGrogan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Preoperative chemotherapy treatment of breast cancer - A review
Aman U. Buzdar
CANCER (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Share Paper
